Research and analysis

GSK: Evaluation of excess mortality in European all-cause mortality data, 25 September 2020

Paper prepared by GlaxoSmithKline (GSK).

• From: Scientific Advisory Group for Emergencies
• Published: 23 October 2020

Documents

Evaluation of excess mortality in European all-cause mortality data - 25 September 2020

PDF, 1.05 MB, 17 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email contact@go-science.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Paper by GSK on excess mortality in Europe. It was considered at SAGE 60 on 1 October 2020.

The paper is the assessment of the evidence at the time of writing. As new evidence or data emerges, SAGE updates its advice accordingly.

These documents are released as pre-print publications that have provided the government with rapid evidence during an emergency. These documents have not been peer-reviewed and there is no restriction on authors submitting and publishing this evidence in peer-reviewed journals.

Published 23 October 2020